top of page
TECHNOLOGY
Advanced Biologics was initially formed in 2009 when it introduced the innovative OsteoAMP® product line to the orthopaedic and neurosurgery markets. OsteoAMP was divested in 2014 to Bioventus.
Subsequent technology introductions include a cellular bone matrix, OsseoGEN®, and an allograft derived growth factor, ProteiOS®. Both currently being distributed by Biologica Technologies.
OsseoGEN is Advanced Biologics' cell based allograft matrix distributed by Biologica Technologies. For additional information, click on this link.
![Cap Off[2].jpg](https://static.wixstatic.com/media/c7a342_1c19bf801e7d4bb4800ecbdef2ccc28c~mv2.jpg/v1/crop/x_704,y_422,w_2591,h_2592/fill/w_114,h_114,al_c,q_80,usm_0.66_1.00_0.01,enc_auto/Cap%20Off%5B2%5D.jpg)
ProteiOS is Advanced Biologics' allograft derived growth factor distributed by Biologica Technologies. For additional information, click on this link.
bottom of page